A detailed history of O'Dell Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, O'Dell Group, LLC holds 1,881 shares of NVO stock, worth $166,863. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,881
Holding current value
$166,863
% of portfolio
0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $223,970 - $273,535
1,881 New
1,881 $223,000
Q4 2023

Feb 15, 2024

BUY
$87.78 - $105.45 $20,013 - $24,042
228 New
228 $23,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $7,019 - $7,769
45 New
45 $7,000
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $5,234 - $6,610
62 New
62 $6,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track O'Dell Group, LLC Portfolio

Follow O'Dell Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Dell Group, LLC with notifications on news.